This makes for an excellent read. It’s good to see that they are emphasising both cost and clinical effectiveness. The stats on the out of control growth of patients with diabetic ulcers is an eye-opener!
This makes for an excellent read. It’s good to see that they are...
-
- There are more pages in this discussion • 467 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PNV (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$2.68 |
Change
0.100(3.88%) |
Mkt cap ! $1.849B | |||
| Open | High | Low | Value | Volume |
| $2.60 | $2.69 | $2.56 | $4.843M | 1.830M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 4688 | $2.67 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $2.68 | 87980 | 4 |
View Market Depth
| Last trade - 16.10pm 31/07/2024 (20 minute delay) ? |
| PNV (ASX) Chart |